Mi Qi
Impact in
-
- Immunotherapy and Immune Responses
- Immune cells in cancer
-
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Respiratory viral infections research 3
- Influenza Virus Research Studies 3
- Virology and Viral Diseases 1
-
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Xiaowei Zhang (6 shared papers)Xian‐En Zhang (6 shared papers)Zongqiang Cui (6 shared papers)Zhiping Zhang (4 shared papers)Wei Li (1 shared paper)Jianjun Chen (3 shared papers)Ze Chen (2 shared papers)Siling Liu (2 shared papers)
- Journals
- Small (2 papers)Molecular Therapy (1 paper)Nano Letters (1 paper)ACS Nano (1 paper)Nanoscale (1 paper)
- Partner nations
- China
In The Last Decade
Mi Qi
8 papers receiving 366 citations
Peers
Comparison fields: 5 of 71
- Immunology 121
- Infectious Diseases 82
- Biomaterials 46
- Animal Science and Zoology 29
- Epidemiology 83
Countries citing papers authored by Mi Qi
This map shows the geographic impact of Mi Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi Qi more than expected).
Fields of papers citing papers by Mi Qi
This network shows the impact of papers produced by Mi Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi Qi. The network helps show where Mi Qi may publish in the future.
Co-authors
The 21 scholars most cited alongside Mi Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 102 | |
| 2 | 2018 | 89 | |
| 3 | 2020 | 76 | |
| 4 | 2023 | 52 | |
| 5 | 2020 | 20 | |
| 6 | 2022 | 19 | |
| 7 | 2024 | 11 | |
| 8 | 2018 | 3 |
About Mi Qi
Mi Qi is a scholar working on Epidemiology, Infectious Diseases, Immunology, Molecular Biology and Cardiology and Cardiovascular Medicine, having authored 8 papers that have together received 372 indexed citations. Recurring topics across this work include Respiratory viral infections research (3 papers), Influenza Virus Research Studies (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Virology and Viral Diseases (1 paper), Mosquito-borne diseases and control (1 paper), Viral Infections and Immunology Research (1 paper), interferon and immune responses (1 paper) and Atherosclerosis and Cardiovascular Diseases (1 paper). The work is most often cited by research in Immunology (121 citations), Infectious Diseases (82 citations), Biomaterials (46 citations), Animal Science and Zoology (29 citations) and Epidemiology (83 citations). Mi Qi has collaborated with scholars based in China. Frequent co-authors include Xiaowei Zhang, Xian‐En Zhang, Zongqiang Cui, Zhiping Zhang, Wei Li, Jianjun Chen, Ze Chen, Siling Liu, Wei Li and Yanfeng Yao. Their work appears in journals such as Small, Molecular Therapy, Nano Letters, ACS Nano and Nanoscale.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.